DeQuardo J R, Carpenter C F, Tandon R
Schizophrenia Program, University of Michigan Medical Center, Ann Arbor 48109-0116.
J Psychiatr Res. 1994 May-Jun;28(3):267-75. doi: 10.1016/0022-3956(94)90010-8.
Recent literature suggests that the increasingly prevalent problem of substance abuse may have important implications for the symptoms and course of schizophrenia. To further examine the impact of substance abuse on this disorder, the clinical and research charts of 67 schizophrenic patients admitted to the Schizophrenia Program of the University of Michigan between 1987 and 1990 were reviewed and data on symptomatology, history of substance use, age at onset and first hospitalization, and family psychiatric history were gleaned. This information was analyzed with respect to clinical, demographic, and outcome variables with the following findings: (i) female subjects abused substances at a much lower rate (20%) than male subjects (48%); (ii) substance-abusing patients with schizophrenia had lower pre- and post-treatment Hamilton Rating Scale of Depression scores, poorer post-discharge treatment compliance, and were younger at first hospitalization than were non-abusing patients; (iii) the most often abused substance was cannabis (28%) followed closely by alcohol (21%), with cocaine, hallucinogens, and stimulants all abused by significantly fewer patients; (iv) rates of family history of schizophrenia were similar in substance-abusing and non-substance-abusing schizophrenic patients. These data suggest that substance abuse may not be etiologically related to schizophrenia but influences the onset, course, and symptomatology of schizophrenia.
近期的文献表明,药物滥用这一日益普遍的问题可能对精神分裂症的症状及病程具有重要影响。为进一步研究药物滥用对该疾病的影响,我们回顾了1987年至1990年间入住密歇根大学精神分裂症项目的67例精神分裂症患者的临床及研究记录,并收集了有关症状学、药物使用史、发病年龄及首次住院年龄以及家族精神病史的数据。针对临床、人口统计学及预后变量对这些信息进行分析后,得出以下结果:(i)女性药物滥用率(20%)远低于男性(48%);(ii)患有精神分裂症的药物滥用患者治疗前及治疗后的汉密尔顿抑郁量表评分较低,出院后治疗依从性较差,且首次住院时年龄比非药物滥用患者更小;(iii)最常被滥用的药物是大麻(28%),紧随其后的是酒精(21%),滥用可卡因、致幻剂和兴奋剂的患者明显较少;(iv)药物滥用的精神分裂症患者与非药物滥用的精神分裂症患者的精神分裂症家族史发生率相似。这些数据表明,药物滥用可能与精神分裂症不存在病因学关联,但会影响精神分裂症的发病、病程及症状表现。